Thoratec Corporation THOR entered into an Agreement and Plan of Merger with Levitronix LLC, a Delaware limited liability company, Revere Merger Sub, LLC, a Delaware limited liability company and wholly-owned subsidiary of Thoratec, Pharos, LLC, a Delaware limited liability company, Levitronix Technologies, LLC, a Delaware limited liability company, certain former members of Levitronix, certain members of Pharos and Pharos, as Seller Representative.
The aggregate value of the cash consideration paid at the closing of the Acquisition was approximately $110.0 million. In addition, earn-out payments up to an aggregate amount of $40.0 million will be payable over four years, contingent upon the achievement of certain minimum revenues generated through sales of Levitronix Medical's products.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in